Close Menu

Meridian Bioscience

NEW YORK (GenomeWeb) — Meridian Biosciences today reported a 6 percent year-over-year increase in fiscal second quarter revenues as growth in its Illumigene molecular assay product portfolio helped temper flagging sales of its influenza immunoassay.

Quest Diagnostics said this week that its Focus Diagnostics business has received expedited 510(k) clearance from the US Food and Drug Administration and CLIA moderate complexity categorization for its Simplexa HSV 1&2 Direct molecular test o

NEW YORK (GenomeWeb News) — Meridian Bioscience said today that it has received US Food and Drug Administration clearance for its Illumigene Bordetella pertussis molecular diagnostic test.

Bioline, a Meridian Bioscience company, this week launched the EPIK Quantification and EPIK Amplification kits.

Sygnis said this week that Qiagen has launched the first two products of a series of kits based on Sygnis' proprietary SensiPhi amplification technology.

NEW YORK (GenomeWeb News) — Meridian Bioscience today reported a 1 percent year-over-year drop in fiscal 2014 first-quarter revenues with mixed results in both its Illumigene molecular diagnostics and core life science businesses.

Meridian Bioscience today reported $44.8 million in preliminary revenue for its fiscal first quarter, marking a 1 percent decline from the year-ago period. Preliminary revenues included $34.8 million in sales from its Diagnostic segment, a 2 percent decline from fiscal Q1 2013.

NEW YORK (GenomeWeb News) - Meridian Bioscience today reported $44.8 million in preliminary revenue for its fiscal first quarter, marking a 1 percent decline from the year-ago period and falling short of consensus analyst estimates of $49 million.

Scientists from UK-based molecular diagnostics developer Lumora have published a pilot study demonstrating how a new heat elution-based sample prep method can be combined with isothermal amplification and Lumora's bioluminescent assay in real-time (BART) readout technology to qui

RainDance Technologies this week announced it has added a high-precision chromosomal copy number variation measurement application to its RainDrop Digital PCR system.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.